[go: up one dir, main page]

JP2022140430A5 - - Google Patents

Download PDF

Info

Publication number
JP2022140430A5
JP2022140430A5 JP2022052554A JP2022052554A JP2022140430A5 JP 2022140430 A5 JP2022140430 A5 JP 2022140430A5 JP 2022052554 A JP2022052554 A JP 2022052554A JP 2022052554 A JP2022052554 A JP 2022052554A JP 2022140430 A5 JP2022140430 A5 JP 2022140430A5
Authority
JP
Japan
Prior art keywords
tablet
tablet according
group
cellulose
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022052554A
Other languages
English (en)
Japanese (ja)
Other versions
JP7511596B2 (ja
JP2022140430A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2022140430A publication Critical patent/JP2022140430A/ja
Publication of JP2022140430A5 publication Critical patent/JP2022140430A5/ja
Application granted granted Critical
Publication of JP7511596B2 publication Critical patent/JP7511596B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022052554A 2021-03-10 2022-03-09 リバーロキサバン含有錠剤 Active JP7511596B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021074453 2021-03-10
JP2021074453 2021-03-10

Publications (3)

Publication Number Publication Date
JP2022140430A JP2022140430A (ja) 2022-09-26
JP2022140430A5 true JP2022140430A5 (ru) 2023-11-10
JP7511596B2 JP7511596B2 (ja) 2024-07-05

Family

ID=83399839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022052554A Active JP7511596B2 (ja) 2021-03-10 2022-03-09 リバーロキサバン含有錠剤

Country Status (1)

Country Link
JP (1) JP7511596B2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118001245B (zh) * 2024-03-13 2024-08-27 广东粤和泽药物研究有限公司 一种利伐沙班口腔崩解片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1100469T3 (da) * 1998-07-28 2005-04-18 Takeda Pharmaceutical Hurtigt henfaldende fast præparat
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CN105457036A (zh) 2014-08-08 2016-04-06 天津汉瑞药业有限公司 一种利伐沙班药物组合物及其制备方法
US20190046449A1 (en) * 2016-02-25 2019-02-14 Mylan Inc. A unique high-shear granulation process for improved bioavailability of rivaroxaban
JP6574041B2 (ja) * 2017-12-15 2019-09-11 エルメッド株式会社 リバーロキサバン含有医薬組成物
WO2020066392A1 (ja) * 2018-09-25 2020-04-02 日新製薬株式会社 経口固形製剤およびその製造法
CN111355313A (zh) * 2018-12-24 2020-06-30 日本电产株式会社 一种轴向磁通马达以及电气产品
CN109620961A (zh) * 2019-01-20 2019-04-16 黄泳华 由吗啉酮衍生物与纤维素衍生物构成的组合物
JP7465157B2 (ja) 2020-06-15 2024-04-10 沢井製薬株式会社 リバーロキサバン含有口腔内崩壊錠の製造方法

Similar Documents

Publication Publication Date Title
JP2013530952A5 (ru)
JP5289338B2 (ja) 医薬固形製剤及びその製造方法
WO2013054872A1 (ja) ７－［４－（４－ベンゾ［ｂ］チオフェン－４－イル－ピペラジン－１－イル）ブトキシ］－１Ｈ－キノリン－２－オン又はその塩を含む錠剤
JP2011098964A5 (ru)
JP2020500176A (ja) 医薬製剤
HRP20240200T1 (hr) Oralne formulacije inhibitora kardijskih sarkomera
US20130344150A1 (en) Direct compression tablets of otilonium
JP2022140430A5 (ru)
RU2011134713A (ru) Фармацевтические композиции, включающие пролекарство ингибитора полимеразы hcv
CA3089537A1 (en) Pharmaceutical compositions comprising ibrutinib
US20150045400A1 (en) Ritonavir compositions
US20210267908A1 (en) Pharmaceutical compositions of rivaroxaban
AU2016231883B2 (en) Pharmaceutical compositions of dimethyl fumarate
AU782005B2 (en) Immediate release medicinal compositions for oral use
JP7226697B2 (ja) ブロナンセリン含有錠剤
JP2018172359A (ja) 適量のビニルピロリドンの重合体を含む、エゼチミブ含有錠剤
JP6688310B2 (ja) テノホビルジソプロキシル遊離塩基を含む錠剤およびその製造方法
JP2020090464A5 (ru)
JP2015071556A (ja) 錠剤及びその製造方法
JP2018184381A (ja) エゼチミブ含有錠剤およびその製法
WO2017037645A1 (en) Stable pharmaceutical formulations of teriflunomide
JP2020196697A (ja) Ｌ−システイン配合ビタミンｃ高含有圧縮成形製剤
JP2019089758A (ja) セレコキシブ含有錠剤における溶出性の改善方法
AU2007101090A4 (en) Process for the preparation of a solid pharmaceutical dosage form
JP2018127417A (ja) フェブキソスタット含有口腔内崩壊錠